Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada

By sjmartinez • September 29, 2022

Moallef S, Genberg BL, Hayashi K, Mehta SH, Kirk GD, Choi J, DeBeck K, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ. Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada. Drug Alcohol Depend. 2022 Sep 15:109633. doi: 10.1016/j.drugalcdep.2022.109633. Epub ahead of print. PMID: 36171158.

Tags: Addiction, COVID-19 Pandemic, Drug Overdose, General Internal Medicine, Harm Reduction, People who use drugs, public health, Publications

A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity

Esquenazi A, Wein TH, Verduzco-Gutierrez M, Ayyoub Z, Page S, Harding S, Maisonobe P, Beneteau M, Patel A; DIRECTION study group. A Phase IV, Randomized,[...]

Dynamic Bayesian networks to predict loss of kidney function: a cross-institution use case in a large cohort with or at-risk of CKD

Petousis P, Gordon D, Duru OK, Norris KC, Tuttle KR, Nicholas SB, Bui AAT. Dynamic Bayesian networks to predict loss of kidney function: a cross-institution[...]

The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women’s Health Initiative

Hossain R, Laddu D, Crandall CJ, Ensrud KE, Cauley JA, Gabriel KP, Haring B, Hardy ST, LeBoff MS, Manson JE, Schwartz AV, Shadyab AH, Watts[...]